Małodobra-Mazur M, Alama A, Bednarska-Chabowska D, Pawelka D, Myszczyszyn A, Dobosz T. Obesity-induced Insulin Resistance via Changes in the DNA Methylation Profile of Insulin Pathway Genes. Adv Clin Exp Med 2019; 28(12):1599-1607. doi: 10.17219/acem/110321.
Shulman GI. Ectopic fat in insulin resistance, dyslipidemia, and cardiometabolic disease. N Engl J Med 2014; 371(12):1131-1141. doi: 10.1056/NEJMra1011035
Liu L, Feng J, Zhang G, Yuan X, Li F, Yange T et al. Visceral adipose tissue is more strongly associated with insulin resistance than subcutaneous adipose tissue in Chinese subjects with pre-diabetes. Curr Med Res Opin 2018; 34(1):123-129. doi: 10.1080/03007995.2017.1364226
Lalia AZ, Dasari S, Johnson ML, Robinson MM, Konopka AR, Distelmaier K et al. Predictors of Whole-Body Insulin Sensitivity Across Ages and Adiposity in Adult Humans. J Clin Endocrinol Metab 2016; 101(2):626-634. doi: 10.1210/jc.2015-2892
Gonzalez N, Moreno-Villegas Z, Gonzalez-Bris A, Egido J, Lorenzo Ó. Regulation of visceral and epicardial adipose tissue for preventing cardiovascular injuries associated to obesity and diabetes. Cardiovasc Diabetol 2017;16(1):44. doi: 10.1186/s12933-017-0528-4
Nielsen S, Guo Z, Johnson CM, Hensrud DD, Jensen MD. Splanchnic lipolysis in human obesity. J Clin Invest 2004; 113(11):1582-1588. doi: 10.1172/JCI21047
Preis SR, Massaro JM, Hoffmann U, D'Agostino Sr RB, Levy D, Robins SJ et al. Neck circumference as a novel measure of cardiometabolic risk: the Framingham Heart study. J Clin Endocrinol Metab 2010; 95(8):3701-3710. doi: 10.1210/jc.2009-1779
Stabe C, Vasques ACJ, Lima MMO, Tambascia MA, Pareja JC, Yamanaka A et al. Neck circumference as a simple tool for identifying the metabolic syndrome and insulin resistance: results from the Brazilian Metabolic Syndrome Study. Clin Endocrinol (Oxf) 2013; 78(6):874-881. doi: 10.1111/j.1365-2265.2012.04487.x.
Britton KA, Massaro JM, Murabito JM, Kreger BE, Hoffmann U, Fox CS. Body fat distribution, incident cardiovascular disease, cancer, and all-cause mortality. J Am Coll Cardiol 2013; 62(10):921-925. doi: 10.1016/j.jacc.2013.06.027
Kihara S, Matsuzawa Y. Fat distribution and cardiovascular disease risk. Curr Cardiovasc Risk Rep 2015; 9(3):8. https://doi.org/10.1007/s12170-015-0439-4
Fan H, Li X, Zheng L, Chen X, Lan Q, Wu H et al. Abdominal obesity is strongly associated with Cardiovascular Disease and its Risk Factors in Elderly and very Elderly Community-dwelling Chinese. Sci Rep 2016; 6:21521. doi: 10.1038/srep21521.
Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18(6):499-502.
Muniyappa R, Lee S, Chen H, Quon MJ. Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage. Am J Physiol Endocrinol Metab 2008; 294(1):E15-E26. doi: 10.1152/ajpendo.00645.2007
Stumvoll M, Van Haeften T, Fritsche A, Gerich J. Oral glucose tolerance test indexes for insulin sensitivity and secretion based on various availabilities of sampling times. Diabetes Care 2001; 24(4):796-797. doi: 10.2337/diacare.24.4.796.
Keskin M, Kurtoglu S, Kendirci M, Atabek ME, Yazici C. Homeostasis model assessment is more reliable than the fasting glucose/insulin ratio and quantitative insulin sensitivity check index for assessing insulin resistance among obese children and adolescents. Pediatrics 2005; 115(4):e500-503. doi: 10.1542/peds.2004-1921.
Ginsberg HN. Insulin resistance and cardiovascular disease. J Clin Invest 2000; 106(4):453-458. doi: 10.1172/JCI10762.
Argiles JM, Lopez-Soriano FJ. Insulin and cancer. Int J Oncol 2001; 18(4):683-687. https://doi.org/10.3892/ijo.18.4.683
Zhang Y, Lee ET, Howard BV, Best LG, Umans JG, Yeh J et al. Insulin resistance, incident cardiovascular diseases, and decreased kidney function among nondiabetic American Indians: the Strong Heart Study. Diabetes Care 2013; 36(10):3195-3200. doi: 10.2337/dc12-2368
McFarlane SI, Banerji M, Sowers JR. Insulin Resistance and Cardiovascular Disease. J Clin Endocrinol Metab 2001; 86(2):713-718. doi: 10.1210/jcem.86.2.7202.
Ferreira AP, Oliveira C, França NM. Metabolic syndrome and risk factors for cardiovascular disease in obese children: the relationship with insulin resistance (HOMA-IR). J Pediatr (Rio J) 2007; 83(1):21-26. doi: 10.2223/JPED.1562.
Wilcox G. Insulin and insulin resistance. Clin Biochem Rev 2005; 26(2):19.
Revers RR, Kolterman OG, Olefsky JM. Relationship between serum glucose level and the metabolic clearance rate of glucose in non-insulin-dependent diabetes mellitus. Diabetes 1983; 32(7):627-632. doi: 10.2337/diab.32.7.627.
Stumvoll M, Mitrakou A, Pimenta W, Jenssen T, Yki-Järvinen H, Van Haeftene T et al. Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity. Diabetes Care 2000; 23(3):295-301. doi: 10.2337/diacare.23.3.295.
Lee CC, Haffner SM, Wagenknecht LE, Lorenzo C, Norris JM, Bergman RN et al. Insulin clearance and the incidence of type 2 diabetes in Hispanics and African Americans: the IRAS Family Study. Diabetes Care 2013; 36(4):901-907. doi: 10.2337/dc12-1316
Akinlade KS, Rahamon SK, Lasebikan VO. Beta-cell Function and Metabolic Clearance Rate of Glucose in Patients with Major Mental Health Disorders on Antipsychotic Drug Treatment. J Natl Med Assoc 2018; 110(5):504-511. doi: 10.1016/j.jnma.2018.01.003.